Business Trends

May 14, 2018
By BioPharm International Editors
Barriers impede biosimilar market entry into the United States despite the Biologics Price Competition and Innovation Act.
May 09, 2018
By BioPharm International Editors
Takeda expands its global and therapy base with announced acquisition of Shire.
May 07, 2018
Smaller review divisions will bring experts closer to decision processes and reduce bottlenecks, FDA leaders say.
May 01, 2018
BioPharm International
While technology promises advances for healthcare, a skilled workforce is needed to deliver on the potential.
Apr 19, 2018
By BioPharm International Editors
The transaction is part of Merck KGaA’s strategy to actively shape its product portfolio and focus on innovation-driven business.
Apr 19, 2018
By BioPharm International Editors
Global investment firm Advent to acquire and invest in Sanofi’s European generics business, Zentiva, to boost its position in European market.
Apr 17, 2018
By BioPharm International Editors
Industry experts will discuss lyophilization best practices and continuous manufacturing for biopharmaceuticals.
Apr 11, 2018
By BioPharm International Editors
The biopharmaceutical firm has chosen Rhode Island as the site of its next-generation biomanufacturing plant, which will offer flexibility, speed, and efficiency.
Apr 01, 2018
BioPharm International
More diversified therapies and tighter payer budgets will challenge bio/pharma companies to think outside the industry.
Mar 30, 2018
By BioPharm International Editors
The company’s close communication with customers has enabled it to bring advanced pipetting products to market.
native1_300x100
lorem ipsum